1
|
Nguyen R, Barry M, Azevedo Loiola R, Ferret PJ, Andres E. PhotoSENSIL-18 assay development: Enhancing the safety testing of cosmetic raw materials and finished products to support the in vitro photosensitization assessment? Toxicology 2023; 495:153613. [PMID: 37558156 DOI: 10.1016/j.tox.2023.153613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 07/07/2023] [Accepted: 08/06/2023] [Indexed: 08/11/2023]
Abstract
Although photosensitization remains a major toxicological endpoint for the safety assessment of cosmetic products and their raw materials, there is no validated in vitro method available for the evaluation of this adverse effect so far. Given that previous studies have proposed that the Interleukine-18 (IL-18) plays a key role in keratinocyte-driven pro-inflammatory responses specific of the skin sensitization process, we hypothesize that IL-18 might be used as a specific biomarker for in vitro photosensitization assessment. The aim of the present study was the set-up of a new in vitro assay using IL-18 as a biomarker for the identification of photosensitizers in a reconstructed human epidermis (RHE) model. EpiCS™ RHE were incubated with a set of 16 known sensitising / phototoxic / photosensitizing substances and exposed to ultra-violet (UV) irradiation. Then, the cell viability was analysed by MTT assay, while the IL-18 secretion was quantified by ELISA. Preliminary assays have shown that 1 h of incubation followed by a recovery period of 23 h induced the highest IL-18 production in response to UV exposure. This protocol was used to test 16 substances and a ratio of IL-18 production (UV+/UV- ratio) was then generated. Our data shows that the cut-off of 1.5 (UV+/UV- ratio) is the most predictive model among the tested conditions, being capable of identifying true positive photosensitizers (8 of 9) with a good prediction in comparison with in vivo data. In a nutshell, our data suggests that the PhotoSENSIL-18 is a promising in vitro method for identification of photosensitizing substances. Although further studies are necessary to optimize the model, we foresee that the PhotoSENSIL-18 assay can be used in the context of an Integrative Approach to Testing and Assessment (IATA) of chemicals.
Collapse
Affiliation(s)
- R Nguyen
- Laboratoires Pierre Fabre, 3 avenue Hubert Curien, BP 13562, 31035 Toulouse Cedex, France
| | - M Barry
- Oroxcell SAS, 102 avenue Gaston Roussel, 93230 Romainville, France
| | - R Azevedo Loiola
- Oroxcell SAS, 102 avenue Gaston Roussel, 93230 Romainville, France
| | - P-J Ferret
- Laboratoires Pierre Fabre, 3 avenue Hubert Curien, BP 13562, 31035 Toulouse Cedex, France
| | - E Andres
- Oroxcell SAS, 102 avenue Gaston Roussel, 93230 Romainville, France.
| |
Collapse
|
2
|
Zulfiqar AA, Boulefred A, Dembélé IA, Amadou N, Traoré AK, Doucet J, Andres E. [Diabetes and frailty in the elderly. A prospective study of an outpatient population supported by general practitioners]. Rev Med Liege 2021; 76:817-823. [PMID: 34738756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
INTRODUCTION Elderly people with diabetes represent a large and growing part of the general practitioners patient database, but their state of frailty compared to the non-diabetic population is poorly understood. OBJECTIVE To study the relationship between diabetes and frailty in people aged 65 and over in primary care. METHOD Frailty syndrome was assessed by the Fried Scale and compared between populations of diabetic and non-diabetic patients; 268 patients were studied, including 129 diabetic patients. RESULTS Frailty was found in 27.9 % of older diabetic patients. The observed mean Fried score was 1.76 in people with diabetes versus 1.39 in non-diabetics, with more frail diabetic subjects (p = 0.007). In this study, HbA1c levels showed no significant association to frailty. CONCLUSION Larger studies in several general practice clinics should be performed on subjects over 65 years of age with or without diabetes.
Collapse
Affiliation(s)
- A A Zulfiqar
- Département de Médecine interne, Clinique médicale B, Hôpitaux Universitaires de Strasbourg, France
| | - A Boulefred
- Médecine générale, Département de Médecine générale, Université de Médecine Générale de Reims, France
| | - I A Dembélé
- Département de Médecine interne, Clinique médicale B, Hôpitaux Universitaires de Strasbourg, France
| | - N Amadou
- Département de Médecine interne, Clinique médicale B, Hôpitaux Universitaires de Strasbourg, France
| | - A K Traoré
- Département de Médecine interne, CHU Point G, Bamako, Mali
| | - J Doucet
- Service de Médecine interne polyvalente et thérapeutique, Hôpital Saint-Julien, CHU Rouen, France
| | - E Andres
- Département de Médecine interne, Clinique médicale B, Hôpitaux Universitaires de Strasbourg, France
| |
Collapse
|
3
|
Zulfiqar AA, Dembele IA, Amadou N, Doucet J, Andres E. [Type 2 diabetes and the elderly : a real problem]. Rev Med Liege 2021; 76:752-755. [PMID: 34632745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Type 2 diabetes in the elderly remains a major concern for all healthcare professionals, this disease being considered a real global «pandemic». Its prevalence is high and will continue to increase in the years to come, becoming significant in the elderly and the very old. We offer you a general summary and a focus on diabetes in the elderly with the GERODIAB study.
Collapse
Affiliation(s)
- A A Zulfiqar
- Département de Médecine interne, Clinique Médicale B, Hôpitaux Universitaires de Strasbourg, France
| | - I A Dembele
- Département de Médecine interne, Clinique Médicale B, Hôpitaux Universitaires de Strasbourg, France
| | - N Amadou
- Département de Médecine interne, Clinique Médicale B, Hôpitaux Universitaires de Strasbourg, France
| | - J Doucet
- Service de Médecine interne polyvalente, Hôpital Saint-Julien, CHU, Rouen, France
| | - E Andres
- Département de Médecine interne, Clinique Médicale B, Hôpitaux Universitaires de Strasbourg, France
| |
Collapse
|
4
|
Greuez C, Argemi X, Giorgiutti S, Goichot B, Hannedouche T, Kaltenbach G, Lefebvre N, Lenormand C, Lescuyer S, Moulin B, Rondeau-Lutz M, Schmitt E, Sibilia J, Imperiale A, Andres E. Fièvre et syndrome inflammatoire inexpliqué chez le sujet âgé, impact thérapeutique de la TEP-TDM au 18F-FDG. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.03.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
5
|
Cordeanu E, Jambert L, Lambach H, Tousch J, Heitz M, Mirea C, Frantz A, Younes W, Delatte A, Woehl B, Bilbault P, Ohlmann P, Meziani F, Andres E, Stephan D. Outcomes of hospitalized patients with SARS-CoV-2 infection previously treated with renin-angiotensin system inhibitors. Archives of Cardiovascular Diseases Supplements 2021. [PMCID: PMC7803093 DOI: 10.1016/j.acvdsp.2020.10.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Background Renin angiotensin system inhibitors (RASi) are largely prescribed in hypertensive patients. As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) penetrates respiratory epithelium through angiotensin converting enzyme 2 (ACE2) binding, the association between RASi and poorer outcomes has been questioned. Purpose This study aimed to provide insight on the impact of RASi on SARS-CoV-2 outcomes in a population of patients hospitalized for COVID-19. Methods This is a retrospective analysis of consecutively hospitalized adult patients with SARS-CoV-2 infection (positive rtPCR) admitted to the University Hospital of Strasbourg from the 25th Feb, 2020 to the 1st Apr, 2020. Patients hospitalized for less than 24 h were excluded and the observation period ended at hospital discharge. Results During the study period, 943 COVID-19 patients were hospitalized in our institution, of whom 772 were included in this analysis. Among them, 431 patients had previously known hypertension. The median age was 68 (56–79). The cohort was divided into two subgroups based on RASi treatment on admission: “RASi” (n = 282) and “RASi-free” (n = 490). Both groups had similar clinical presentations and equivalent recourse to endotracheal intubation, high flow nasal oxygen (HFNO) or non-invasive ventilation (NIV). Overall, 220 patients were placed under mechanical ventilation of whom 30% died. Severe pneumonia (defined as either leading to death, and/or requiring intubation, HFNO, NIV and/or requiring an oxygen rate flow ≥ 5l/min) and death occurred more frequently in RASi treated patients (63% vs. 53% and respectively 27.3% versus 18.2%). In a multivariate logistic-regression model, neither severe pneumonia nor death were associated with RASi treatment. Conclusion Our study showed no correlation between RASi treatment and death or severe COVID-19 pneumonia.
Collapse
|
6
|
Cordeanu E, Lambach H, Tousch J, Jambert L, Mirea C, Heitz M, Frantz A, Delatte A, Younes W, Woehl B, Bilbault P, Ohlmann P, Andres E, Meziani F, Stephan D. Venous thromboembolism frequency in patients hospitalized for SARS-CoV-2 infection. Archives of Cardiovascular Diseases Supplements 2021. [PMCID: PMC8719937 DOI: 10.1016/j.acvdsp.2020.10.145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Background SARS-CoV-2 infection was associated with a higher thrombotic risk, partially explained by intense systemic inflammatory reaction, longer hospitalizations and intubations as well as central catheters and extracorporeal membrane oxygenation devices. Intrinsic thrombotic potential is questioned as certain patients had plasma lupus anticoagulant (LAC). Purpose This study aimed to evaluate the frequency of venous thromboembolism (VTE) among adult patients hospitalized for COVID-19. Methods This is a retrospective analysis of consecutively hospitalized adult patients with SARS-CoV-2 infection (positive rtPCR) admitted to the University Hospital of Strasbourg from the 25th Feb, 2020 to the 1st Apr, 2020. Patients hospitalized for less than 24 h were excluded and the observation period ended at hospital discharge. Results During the study period, 943 COVID-19 patients were hospitalized in our institution, of whom 772 were included in this analysis. The median age was 68 (56–79) years old and 58 patients had previously known VTE. Overall, VTE occurred in 60 patients (7.8%): 43 pulmonary embolisms (PE), 15 isolated deep vein thrombosis and 2 superficial vein thrombosis. Of note, 81% of patients had been prescribed an anticoagulant treatment on admission. VTE incidence was higher in patients with more severe forms of pneumonia defined as either leading to death, and/or requiring intubation/high flow nasal oxygen/non-invasive ventilation (21% versus 2%, P < 0.001). Overall mortality was 21% and death rate was higher in patients that presented a VTE event (35% versus 20%, P = 0.012). Among VTE patients, a search for LAC was performed in 72% of them and came back positive in 88% of cases. Overall, 33 major bleeding complications (4.3%) were observed of which 42% were intracranial. Conclusion Our study showed that in-hospital VTE occurred more frequently in case of severe COVID-19 pneumonia and was associated with higher death rates.
Collapse
|
7
|
Trimaille A, Curtiaud A, Marchandot B, Matsushita K, Sato C, Leonard-Lorant I, Sattler L, Grunebaum L, Ohana M, Von Hunolstein J, Andres E, Goichot B, Danion F, Kaeuffer C, Poindron V, Ohlmann P, Jesel L, Morel O. Venous thromboembolism in non-critically ill patients with COVID-19 infection. Archives of Cardiovascular Diseases Supplements 2021. [PMCID: PMC7803092 DOI: 10.1016/j.acvdsp.2020.10.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Background Systemic coagulation activation and thrombotic complications are frequent among critically ill patients with COVID-19. Limited data are available in non-intensive care unit (ICU) patients. Purpose To determine the incidence, risk factors and prognosis of venous thromboembolism (VTE) in non-ICU COVID-19 patients. Methods We studied consecutive COVID-19 patients admitted to general ward at Strasbourg Hospital, France (25.02.2020–19.04.2020). The primary outcome was any VTE complication. The secondary outcome was the composite of death or transfer to ICU. Results Among the 289 patients included (62.2 ± 17.0 years, 59.2% male), VTE occurred in 49 (17.0%). Padua prediction score for VTE was similar between VTE and non-VTE patients. VTE imaging tests were performed in 100 (34.6%) patients and VTE diagnosed in median 7 (3–11) days after admission. On-admission, time from symptom onset to admission (OR 1.07, CI 95% [1.00–1.16], P = 0.045), Improve score (OR 1.37, [1.02–1.83], P = 0.032), leukocyte count (OR 1.16, [1.06–1.27], P = 0.001) and lack of thromboprophylaxis (OR 27.85, CI 95% [9.35–82.95], P < 0.001) were independent predictors of VTE. The incidence of the composite of death or ICU transfer was 31.0% and more frequent among patients with VTE (47.9% vs. 27.9%, P = 0.01). Fever (OR 5.37, CI 95% [1.44–19.97], P = 0.012), VTE (OR 3.44, CI 95% [1.63–7.25], P = 0.001), lymphopenia (OR 0.32, 95% CI [0.15–0.71]; P = 0.005) and extent of COVID-19 evaluated by chest CT severity (OR 1.56, 95% CI [1.12–2.16]; P = 0.007) were independently associated with in-hospital death or transfer to ICU (Table 1, Fig. 1). Conclusions The 17.0% incidence of VTE in non-ICU patients with COVID-19 was associated with worse outcomes. Given the high incidence of VTE in ward patients, there is an urgent need to investigate the optimal anticoagulation regimen.
Collapse
|
8
|
Zulfiqar A, Lorenzo N, Mourot-Cottet R, Goichot B, Maloisel F, Tebacher M, Andres E. Neutropénie sévère et agranulocytose induites par les antithyroïdiens de synthèse : à propos de 30 cas issus d’un centre de référence. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
9
|
Chahbazian J, Lorenzo N, Ben Malek H, Vogel T, Bourgarit A, Andres E, Zulfiqar A. Sémiologie clinique de l’anémie chez des patients âgés de plus de 75 ans : une étude prospective menée par le groupe SiFMI. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
10
|
Delforge J, Sovaila S, Alix L, Didon A, Steichen O, Ranque B, Froissart A, Amadou K, Hanslik T, Cador B, Bergmann JF, Mekininan A, Goujard C, Gayet S, Cathebras P, Fantin B, Raigniac D, Weber JC, Rosenthal E, Hery L, Andres E, Benhamou Y, Bourgarit A. [Characteristics of patients admitted from emergency units in 18 internal medicine departments and organisation of these departments: A cross sectional study from SNFMI (SiFMI study group) in 2015]. Rev Med Interne 2020; 42:79-85. [PMID: 33160706 DOI: 10.1016/j.revmed.2020.09.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2019] [Revised: 08/04/2020] [Accepted: 09/13/2020] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Patients admitted from emergency units represent a large portion of the population in internal medicine departments. The aim of this study is to identify characteristics of patients and organization of these departments. METHODS Between June 29th and July 26th 2015, voluntary internal medicine departments from the SiFMI group prospectively filled anonymized internet forms to collect data of each patients admitted in their ward from emergency units, during seven consecutive days. RESULTS Three hundred and sixty-five patients from emergency departments were admitted in 18 internal medicine inpatients departments, totalling 1100 beds and 33,530 annual stays, 56% of them for emergency units inpatients. Mean age was 68 years, 54% were women, mean Charlson score was 2.6 and 44% of the patients took at least three drugs. Main causes of hospitalization were infectious (29%) and neurological (17%) diseases. Mean length of stay was 9.2 days. The medical team was composed by a median value of 4,5 [2,75-6,25] senior full-time equivalents, 86% were internists. Each department except one received residents, two third of them were from general medicine. CONCLUSION This study highlights a high organizational variability among internal medicine departments and patients, and sets internal medicine as a specialty with a great capacity to achieve an integrative/comprehensive management of patients and to offer a comprehensive basis for physicians in training.
Collapse
Affiliation(s)
- J Delforge
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - S Sovaila
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - L Alix
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France.
| | - A Didon
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - O Steichen
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - B Ranque
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - A Froissart
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - K Amadou
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - T Hanslik
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - B Cador
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - J F Bergmann
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - A Mekininan
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - C Goujard
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - S Gayet
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - P Cathebras
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - B Fantin
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - D Raigniac
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - J C Weber
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - E Rosenthal
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - L Hery
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - E Andres
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - Y Benhamou
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | - A Bourgarit
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| | -
- Service de médecine interne et immunologie clinique, CHU de Rennes, 2 rue Henri-Le-Guilloux, 35000 Rennes, France
| |
Collapse
|
11
|
Habchi H, Lorenzo-Villalba N, Andres E, Zulfiqar AA. [Physical activity among seniors : what benefits on geriatric criteria ?]. Rev Med Liege 2020; 75:89-93. [PMID: 32030932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The elderly population is growing in our societies. Prevention policies are strongly supported by public authorities and one of them is the promotion of physical activity. We propose to detail, through a literature review, the impact of physical activity on the main geriatric criteria.
Collapse
Affiliation(s)
- H Habchi
- Département de Médecine générale, CHU Reims, France
| | | | - E Andres
- Département de Médecine interne, CHRU Strasbourg, France
| | - A A Zulfiqar
- Département de Médecine interne, CHRU Strasbourg, France
| |
Collapse
|
12
|
Zulfiqar AA, Lorenzo Villalba N, Ben Malek H, Vogel T, Andres E, SiFMI G. [Clinical semiology of anemia in patients over 75 years: a prospective study conducted in France by the SiFMI group]. Rev Med Liege 2019; 74:667-671. [PMID: 31833278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
INTRODUCTION Anemia remains one of the main concerns of the day-today life of Internist since it ranks third among the pathologies seen in Internal Medicine Departments. OBJECTIVE it seemed appropriate for the SiFMI Group (Common Situations in Internal Medicine of the SNFMI) to carry out a study of anemia evaluating the contribution to the diagnosis of the «classical» semiology of the anemic syndrome. This work reports the results from the study of 204 patients aged 75 years and more. METHOD A prospective, non interventional multicenter study was carried out in Internal and Geriatric Departments in the period September 2015-September 2017. Clinical and biological variables were collected. RESULTS 204 patients from 10 Internal or Geriatric Departments were included in the period September 2015-September 2017. They were assigned into two groups with and without anemia. According to this study, it seems that the following parameters : asthenia, dyspnea (NYHA stages III and IV), palpitations, chest pain, tachycardia, hypotension as well as confusion, falls, depression and MMSE showed no significant statistical difference between both groups in contrast to pallor, edema, albumin and ECG. CONCLUSION Clinical diagnosis of anemia in elderly individuals remains a challenge. It is difficult to establish a diagnostic protocol in this population.
Collapse
Affiliation(s)
- A A Zulfiqar
- Service de Médecine interne, Diabète et Maladies métaboliques, Hôpitaux Universitaires de Strasbourg, France
| | - N Lorenzo Villalba
- Service de Médecine interne, Diabète et Maladies métaboliques, Hôpitaux Universitaires de Strasbourg, France
| | - H Ben Malek
- Service de Médecine interne, Diabète et Maladies métaboliques, Hôpitaux Universitaires de Strasbourg, France
| | - T Vogel
- Service de Gériatrie et Médecine interne, CHU Strasbourg, France
| | - E Andres
- Service de Médecine interne, Diabète et Maladies métaboliques, Hôpitaux Universitaires de Strasbourg, France
| | - Group SiFMI
- Société Nationale Française de Médecine Interne
| |
Collapse
|
13
|
Ruch Y, Labidi A, Martin A, Weingertner N, Hansmann Y, Lefebvre N, Andres E, Argemi X, Dieudonné Y. Le syndrome de cavitation ganglionnaire mésentérique, complication rare de la maladie cœliaque de l’adulte : à propos de quatre cas et revue de la littérature. Rev Med Interne 2019; 40:536-544. [DOI: 10.1016/j.revmed.2019.05.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2019] [Revised: 05/07/2019] [Accepted: 05/09/2019] [Indexed: 11/28/2022]
|
14
|
Andres E, Meyer L, Talha S, Hajjam A, Hajjam M, Jeandidier N. Télésurveillance du patient diabétique de type 2 et/ou insuffisant cardiaque : l’expérience Strasbourgeoise. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
15
|
Zulfiqar AA, Niazi R, Pennaforte JL, Andres E. [Rheumatoid arthritis and cardiovascular risk factor : literature review]. Rev Med Liege 2018; 73:634-639. [PMID: 30570235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The rheumatoid arthritis remains a common condition and constitutes a diagnostic and therapeutic challenge, especially in the elderly. Rheumatoid arthritis is known to be associated with increased mortality, including coronary and cerebrovascular atherosclerosis. A literature review is conducted on the role of rheumatoid arthritis as a cardiovascular risk factor.
Collapse
Affiliation(s)
- A A Zulfiqar
- Département de Médecine Interne-Gériatrie-Thérapeutique, Hôpital Saint-Julien, CHU Rouen, France
| | - R Niazi
- Département de Médecine Générale, CHU Reims, France
| | - J L Pennaforte
- Département de Médecine Interne, Hôpital Robert Debré, CHU Reims, France
| | - E Andres
- Département de Médecine Interne, Hôpital Central, CHRU Strasbourg, France
| |
Collapse
|
16
|
Andres E, Barry M, Hundt A, Dini C, Ferret PJ. Human tissue based sensitization assessment: set-up of an accurate prediction model for distinguishing skin sensitizers using a new assay adapted to hydrophobic substances and mixtures. Toxicol Lett 2018. [DOI: 10.1016/j.toxlet.2018.06.678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
17
|
Barcham R, Orsini N, Andres E, Hundt A, Luzy AP, Dini C. Successful proof of concept of a micronucleus genotoxicity assay performed on reconstructed epidermis exhibiting intrinsic metabolic activity. Toxicol Lett 2018. [DOI: 10.1016/j.toxlet.2018.06.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Andres E, Kerling F, Hamer H, Winterholler M. Behavioural changes in patients with intellectual disability treated with brivaracetam. Acta Neurol Scand 2018; 138:195-202. [PMID: 29658982 DOI: 10.1111/ane.12943] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/22/2018] [Indexed: 01/26/2023]
Abstract
OBJECTIVE The purpose of this study was to evaluate the tolerability and efficacy of brivaracetam (BRV) in residential patients at our epilepsy centre. PATIENTS AND METHODS We assessed retrospectively 33 patients (14 females; mean age 38.2 years, with range 17-63 years) with intellectual disability (ID) and drug-resistant epilepsy using an industry-independent, non-interventional study design based on standardized daily seizure records. Mean seizure frequency was compared between the 3-month baseline period and subsequent 3-month treatment period. Evaluation, including calculation of retention rate, was carried out for the intervals 3-6 and 9-12 months after brivaracetam initiation. Responders were defined as having a 50% reduction in seizure frequency. The Clinical Global Impression scale (CGI) was applied to allow assessment of qualitative changes in seizure severity, and the Aggressive Behaviour Scale (ABS) gave further insights into challenging behaviour. RESULTS The responder rate was 19%, and one non-responder attained an improvement in CGI score. The retention rate after 12 months was 37%. Brivaracetam treatment was stopped because of adverse events (n = 3), lack of efficacy (n = 8) or both (n = 6). Thirteen patients experienced behavioural changes, with aggressive behaviour being the commonest effect. We also observed ataxia (n = 2), gastrointestinal disorder (n = 3) and sedation (n = 2). The ABS showed deterioration, or new occurrence, of aggressive behaviour in 13 patients. CONCLUSIONS Brivaracetam seems to be effective in a small number of patients suffering from difficult-to-treat epilepsy and intellectual disability. Challenging behaviour was documented in a relevant number of patients, with psychiatric illness being a risk factor for this.
Collapse
Affiliation(s)
- E. Andres
- Department of Neurology; Epilepsy Center; Sana-Krankenhaus Rummelsberg (teaching hospital of the Friedrich-Alexander-Universität Erlangen-Nürnberg); Schwarzenbruck Germany
| | - F. Kerling
- Department of Neurology; Epilepsy Center; Sana-Krankenhaus Rummelsberg (teaching hospital of the Friedrich-Alexander-Universität Erlangen-Nürnberg); Schwarzenbruck Germany
| | - H. Hamer
- Department of Neurology; Friedrich-Alexander-Universität Erlangen-Nürnberg; Erlangen Germany
| | - M. Winterholler
- Department of Neurology; Epilepsy Center; Sana-Krankenhaus Rummelsberg (teaching hospital of the Friedrich-Alexander-Universität Erlangen-Nürnberg); Schwarzenbruck Germany
| |
Collapse
|
19
|
Andres E, Von Hunolstein J, Talha S, Khalil F, Bilbault P, Vogel T, Gény B, Roul G. Profile des patients admis pour décompensation cardiaque aiguë : rôle des internistes. Résultat préliminaires d’une étude prospective auprès de 157 patients. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
20
|
Andres E, Talha S, Hajjam M, Keller O, Hajjam J, Erve S, Hajjam A. Résultats de l’expérimentation d’une plateforme de détection automatisée des situations à risque de décompensation cardiaque auprès de patients présentant des pathologies chroniques, suivis en médecine interne. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.308] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
21
|
Zulfiqar A, Sui Seng X, Gilibert A, Kadri N, Doucet J, Andres E. Anémie chez le sujet âgé : étude des liens avec les critères gériatriques. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
22
|
Mourot-Cottet R, Keller O, Vogel T, Gottenberg J, Herbrecht R, Andres E. Neutropénie fébrile idiosyncrasique : étude de 76 observations. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
23
|
Noël E, Mourot-Cottet R, Andres E. Intérêt du Migalastat, molécule chaperonne, dans le traitement de la maladie de Fabry. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
24
|
Andres E, Kerling F, Hamer H, Kasper B, Winterholler M. Behavioural changes in patients with intellectual disability treated with perampanel. Acta Neurol Scand 2017; 136:645-653. [PMID: 28568478 DOI: 10.1111/ane.12781] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/04/2017] [Indexed: 11/28/2022]
Abstract
OBJECTIVES The aim of this cross-sectional retrospective study was to assess the tolerability and efficacy of perampanel in patients with drug-resistant epilepsy who also suffered from intellectual disability (ID). PATIENTS AND METHODS We used an industry-independent, non-interventional retrospective evaluation based on standardized, daily seizure records. Twenty-seven patients with ID and drug-resistant epilepsy were started on perampanel between September 2012 and November 2015 after a 3-month observation period without perampanel treatment. Perampanel was given at a maximum dosage of 4-12 mg daily. Evaluation was carried out after 6, 12 and 24 months, including calculation of the retention rate. Mean seizure frequency was compared between the 3-month baseline period and subsequent 3-month treatment periods. The Clinical Global Impression scale was applied to assess qualitative changes in seizure severity, and the Aggressive Behaviour Scale (ABS) gave further insights into challenging behaviour. RESULTS Perampanel was efficacious and well tolerated in five of 25 patients. In 18 patients, perampanel treatment was stopped, mainly because of adverse events (n=6), lack of efficacy (n=3) or both (n=9). Behavioural changes were documented in 15 of 27 patients, with aggressive behaviour being the commonest effect; we observed ataxia (n=6) and sedation (n=8) in further patients. The ABS showed worsening of aggressive behaviour in six patients. CONCLUSIONS Perampanel was well tolerated and efficacious in one-fifth of our patients. We observed challenging behaviour, ataxia and sedation in a relevant number of patients with ID under perampanel treatment. Further studies are warranted to explore the tolerability of perampanel in patients with ID.
Collapse
Affiliation(s)
- E. Andres
- Department of Neurology and Epilepsy Center; Sana-Krankenhaus Rummelsberg (teaching hospital of the Friedrich-Alexander-Universität Erlangen-Nürnberg, FAU); Schwarzenbruck Germany
| | - F. Kerling
- Department of Neurology and Epilepsy Center; Sana-Krankenhaus Rummelsberg (teaching hospital of the Friedrich-Alexander-Universität Erlangen-Nürnberg, FAU); Schwarzenbruck Germany
| | - H. Hamer
- Department of Neurology; Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU); Erlangen Germany
| | - B. Kasper
- Department of Neurology; Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU); Erlangen Germany
| | - M. Winterholler
- Department of Neurology and Epilepsy Center; Sana-Krankenhaus Rummelsberg (teaching hospital of the Friedrich-Alexander-Universität Erlangen-Nürnberg, FAU); Schwarzenbruck Germany
| |
Collapse
|
25
|
Andres E, Talha S, Roul G, Bilbault P, Vogel T. Insuffisance cardiaque : rôle des internistes dans la mise en place d’une filière dédiée à la prise en charge de cette affection. Étude de preuve de concept sur 157 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.391] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
26
|
Ram R, Wakil S, Muiya N, Andres E, Mazhar N, Hagos S, Alshahid M, Meyer B, Morahan G, Dzimiri N. A common variant association study in ethnic Saudi Arabs reveals novel susceptibility loci for hypertriglyceridemia. Clin Genet 2017; 91:371-378. [DOI: 10.1111/cge.12859] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2016] [Revised: 08/30/2016] [Accepted: 08/30/2016] [Indexed: 12/15/2022]
Affiliation(s)
- R. Ram
- Centre for Diabetes Research, The Harry Perkinsn Institute for Medical Research Perth WA Australia
- Centre for Medical ResearchUniversity of Western Australia Perth WA Australia
| | - S.M. Wakil
- Genetics DepartmentKing Faisal Specialist Hospital and Research Centre Riyadh KSA
| | - N.P. Muiya
- Genetics DepartmentKing Faisal Specialist Hospital and Research Centre Riyadh KSA
| | - E. Andres
- Genetics DepartmentKing Faisal Specialist Hospital and Research Centre Riyadh KSA
| | - N. Mazhar
- Genetics DepartmentKing Faisal Specialist Hospital and Research Centre Riyadh KSA
| | - S. Hagos
- Genetics DepartmentKing Faisal Specialist Hospital and Research Centre Riyadh KSA
| | - M. Alshahid
- King Faisal Heart InstituteKing Faisal Specialist Hospital and Research Centre Riyadh KSA
| | - B.F. Meyer
- Genetics DepartmentKing Faisal Specialist Hospital and Research Centre Riyadh KSA
| | - G. Morahan
- Centre for Diabetes Research, The Harry Perkinsn Institute for Medical Research Perth WA Australia
- Centre for Medical ResearchUniversity of Western Australia Perth WA Australia
| | - N. Dzimiri
- Genetics DepartmentKing Faisal Specialist Hospital and Research Centre Riyadh KSA
| |
Collapse
|
27
|
Zulfiqar AA, Andres E. Association pernicious anemia and autoimmune polyendocrinopathy: a retrospective study. J Med Life 2017; 10:250-253. [PMID: 29362601 PMCID: PMC5771255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
OBJECTIVE To investigate the association between pernicious anemia and other autoimmune diseases. METHODS This retrospective and bicentric study was conducted at Reims and Strasbourg University Hospitals and involved 188 patients with pernicious anemia examined between 2000 and 2010 in order to search for other autoimmune diseases and to evaluate the role of pernicious anemia in autoimmune polyglandular syndrome. RESULTS A total of 74 patients with a combination of pernicious anemia and other autoimmune diseases were included in the study. Our study revealed the privileged association of pernicious anemia with autoimmune thyroiditis. The association of pernicious anemia and autoimmune thyroiditis are a part of the autoimmune polyglandular syndrome type 3b. CONCLUSION We suggest undertaking a systematic clinical examination and laboratory investigations in search of autoimmune thyroiditis in patient(s) with the diagnosis of pernicious anemia. The association of pernicious anemia and autoimmune thyroiditis is frequent and a part of autoimmune polyglandular 3b.
Collapse
Affiliation(s)
- AA Zulfiqar
- Department of Internal Medicine, Geriatrics, Therapeutics, CHU Rouen, France
| | - E Andres
- Département de Médecine Interne, CHRU Strasbourg, France
| |
Collapse
|
28
|
Kleinmann J, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacré K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau F, Jourde-Chiche N, Kone-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin Silva N, Martin T, Maurier F, Meckenstock R, Mekinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg J. Recommandations francophones, internationales et multidisciplinaires d’experts pour l’utilisation de biomédicaments dans le lupus érythémateux systémique : le groupe de travail du CRI-IMIDIATE. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
29
|
Mercier M, Nivoix Y, Andres E, Gourieux B. Évaluation de la prescription de fer injectable en médecine et chirurgie : étude prospective auprès de 178 patients. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
30
|
Andres E, Mecili M, Zulfiqar A, Keller O, Mourot-Cottet R, Bourgarit-Durand A. Projet d’étude sur la SÉmiologie CArdiaque dans l’Insuffisance Cardiaque en médecine interne (projet SECAIC). Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.136] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
31
|
Mourot-Cottet R, Maloisel F, Séverac F, Keller O, Vogel T, Tebacher M, Weber JC, Kaltenbach G, Goichot B, Gottenberg J, Herbrecht R, Andres E. Agranulocytose médicamenteuse idiosyncratique du sujet âgé : étude d’une série de 61 patients. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
32
|
Zulfiqar A, Chaara T, Estibaliz L, Moulis G, Viallard J, Michel M, Pennaforte J, Andres E, Godeau B. Anémie hémolytique auto-immune chez le sujet âgé de plus de 75 ans : étude rétrospective. Résultats préliminaires. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
33
|
Abstract
Few studies have assessed differences in the prevalence of and economic burden attributable to tobacco smoking, excess weight, physical inactivity, and alcohol use by gender. This article examines these gender differences in Canadians between the ages of 30 and 64 years. It also estimates the potential cost avoidance if the prevalence of the four risk factors (RFs) were reduced modestly in males. Data on the prevalence of the RFs and the relative risk of disease associated with each of the RFs were combined to calculate population-attributable fractions. A prevalence-based cost-of-illness approach was used to estimate the economic burden associated with the four RFs. Middle-aged Canadian males are more likely to smoke tobacco (26.4% vs. 20.2%), consume hazardous or harmful levels of alcohol (14.6% vs. 8.2%), and have excess weight (65.6% vs. 47.1%) than middle-aged Canadian females, resulting in an annual economic burden that is 27% higher in males than females. No significant differences were observed in the proportion of males who are physically inactive (48.4% vs. 49.4%). Modelling only a 1% annual relative reduction each year through to 2036 would result in a cumulative cost avoidance between 2013 and 2036 of $50.7 billion. The differences in RF prevalence between middle-aged males and females have an important effect on the population’s economic burden. A modest annual reduction in the four RFs in males can significantly affect population health and the economy over time.
Collapse
Affiliation(s)
- H Krueger
- 1 University of British Columbia, Vancouver, British Columbia, Canada.,2 H. Krueger & Associates Inc., Delta, British Columbia, Canada
| | - S L Goldenberg
- 1 University of British Columbia, Vancouver, British Columbia, Canada
| | - J Koot
- 1 University of British Columbia, Vancouver, British Columbia, Canada.,2 H. Krueger & Associates Inc., Delta, British Columbia, Canada
| | - E Andres
- 2 H. Krueger & Associates Inc., Delta, British Columbia, Canada
| |
Collapse
|
34
|
Andres E, Barry M, Hundt A, Dini C, Corsini E, Gibbs S, Roggen EL, Ferret PJ. Preliminary performance data of the RHE/IL-18 assay performed on SkinEthic ™ RHE for the identification of contact sensitizers. Int J Cosmet Sci 2016; 39:121-132. [PMID: 27455141 DOI: 10.1111/ics.12355] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2016] [Accepted: 07/21/2016] [Indexed: 12/19/2022]
Abstract
OBJECTIVE The purpose of this study was to evaluate the performances of the RHE/IL-18 assay using the SkinEthic™ RHE model for the identification of contact sensitizers. METHODS A set of 18 substances and mixtures was tested on this epidermal model, following the RHE/IL-18 protocol. The final results of the assay were obtained following 5 interpretation schemes, to determine the optimal prediction model for this assay with this specific test system. The data were analysed with a special focus on the basal level of IL-18 release and on the performance obtained with respect to three different gold standards: LLNA, HRIPT and an integrated reference, constructed from all available results. RESULTS No important differences were found in the performance levels depending on the three gold standards. The performances obtained with the SkinEthic™ RHE model support that this model may be considered as an alternative to different reconstructed epidermis models (EpiDERM™ , EpiCS™ and VUMC-EE) for the performance of RHE/IL-18 assays. CONCLUSION The prediction model to be used was refined, and more substances have to be tested in order to gather enough data for this evaluation and to determine the right criteria applicable for this assay using the SkinEthic™ RHE test system.
Collapse
Affiliation(s)
- E Andres
- Oroxcell, 102 Avenue Gaston Roussel, Romainville, 93230, France
| | - M Barry
- Oroxcell, 102 Avenue Gaston Roussel, Romainville, 93230, France
| | - A Hundt
- Oroxcell, 102 Avenue Gaston Roussel, Romainville, 93230, France
| | - C Dini
- Oroxcell, 102 Avenue Gaston Roussel, Romainville, 93230, France
| | - E Corsini
- Laboratory of Toxicology, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via G. Balzaretti, 9, 20133, Milan, Italy
| | - S Gibbs
- Department of Dermatology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.,Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam, t.a.v. dienst Afspraken & Informatie, University of Amsterdam and VU University, Postbus 7822, 1081 HV, Amsterdam, the Netherlands
| | - E L Roggen
- 3Rs Management & Consulting ApS, Asavaenget 14, 2800 Kongens, Lyngby, Denmark
| | - P-J Ferret
- Institut De Recherche Pierre Fabre, Recherche et Développement Pierre Fabre Dermo Cosmetique, 3 Avenue Hubert Curien, BP 13562, 31035, Toulouse, France
| |
Collapse
|
35
|
Zulfiqar A, Pennaforte J, Kadri N, Doucet J, Andres E. Anémie hémolytique auto-immune : expérience de deux services de médecine interne. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
36
|
Zulfiqar A, Adli AE, Pennaforte J, Kadri N, Doucet J, Andres E. Anémie hémolytique auto-immune (AHIA) du sujet âgé de plus de 75ans : étude rétrospective sur 10 patients. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
37
|
Wakil SM, Ram R, Muiya NP, Andres E, Mazhar N, Hagos S, Alshahid M, Meyer BF, Morahan G, Dzimiri N. A common variant association study reveals novel susceptibility loci for low HDL-cholesterol levels in ethnic Arabs. Clin Genet 2016; 90:518-525. [PMID: 26879886 DOI: 10.1111/cge.12761] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2016] [Revised: 02/08/2016] [Accepted: 02/11/2016] [Indexed: 01/08/2023]
Abstract
The genetic susceptibility to acquiring low high density lipoprotein-cholesterol (LHDLC) levels is not completely elucidated yet. In this study, we performed a common variant association study for harboring this trait in ethnic Arabs. We employed the Affymetrix high-density Axiom Genome-Wide ASI Array (Asian population) providing a coverage of 598,000 single nucleotide variations (SNPs) to genotype 5495 individuals in a two-phase study involving discovery and validation sets of experiments. The rs1800775 [1.31 (1.22-1.42); p = 3.41E-12] in the CETP gene and rs359027 [1.26 (1.16-1.36); p = 2.55E-08] in the LMCD1 gene were significantly associated with LHDLC levels. Furthermore, rs3104435 [1.26 (1.15-1.38); p = 1.19E-06] at the MATN1 locus, rs9835344 [1.16 (1.08-1.26); p = 8.75E-06] in the CNTN6 gene, rs1559997 [1.3 (1.14-1.47); p = 9.48E-06] in the SDS gene and rs1670273 [1.2 (1.1-1.31); p = 4.81E-06] in the DMN/SYNM gene exhibited suggestive association with the disorder. Seven other variants including rs1147169 in the PLCL1 gene, rs10248618 in the DNAH11, rs476155 in the GLIS3, rs7024300 in the ABCA1, intergenic rs10836699, rs11603691 in P2RX3 and rs750134 in CORO1C gene exhibited borderline protective properties. Validation and joint meta-analysis resulted in rs1800775, rs3104435 and rs359027 retaining their predisposing properties, while rs10836699 and rs11603691 showed protective properties. Our data show several predisposing variants across the genome for LHDLC levels in ethnic Arabs.
Collapse
Affiliation(s)
- S M Wakil
- Genetics Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
| | - R Ram
- Western Australian Institute for Medical Research, University of Western Australia, Perth, Australia
| | - N P Muiya
- Genetics Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
| | - E Andres
- Genetics Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
| | - N Mazhar
- Genetics Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
| | - S Hagos
- Genetics Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
| | - M Alshahid
- King Faisal Heart Institute, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - B F Meyer
- Genetics Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
| | - G Morahan
- Western Australian Institute for Medical Research, University of Western Australia, Perth, Australia
| | - N Dzimiri
- Genetics Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
| |
Collapse
|
38
|
Purcarea A, Bourgarit A, Sovaila A, Ghiura C, Diemunsch P, Andres E. Brief report: Serial capillary lactate measurement predict the evolution of early sepsis. J Med Life 2016; 9:74-78. [PMID: 27974919 PMCID: PMC5152613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
OBJECTIVE In intensive care settings, blood lactate level measurement proved to be an excellent predictor of outcomes. In patients requiring less urgent treatment, the arterial blood lactate is less sensitive and its usefulness remains to be proven. Capillary blood lactate dosing, an emergent point-of-care technique readily available should be more sensitive to changes in these settings. METHOD prospective, observational, monocentric study conducted in a polyvalent internal medicine ward in a French University Hospital. The inclusion criteria were the existence of new symptoms of abrupt onset in an otherwise stable patient. All the patients had a point of care measurement of baseline capillary and venous lactate levels (EDGE, ApexBio) and standardized control before any therapeutic means were initiated. A follow-up test was performed once again within 12 to 36 hours. All the patients received standard medical care adapted to their condition. The primary outcomes were considered dying within 30 days or requiring intensive care or invasive therapeutic procedures. RESULTS 13 patients were analyzed. Seven patients reached the composite outcome with 3 deaths. The superimposed complication proved to be infectious in every case. The median lactate levels were at baseline (mmol/ l): capillary Mc0=5.2(2.16), venous Mv0=2.3(2.0) and arterial Ma0=1.8(1.7) and at follow-up (mmol/ l) capillary: Mc1=3.3(1.1), venous Mv1=1.8(1.8) and arterial Ma1=1.3(0.7). In nonparametric analysis, the absence of normalization of capillary lactate at follow-up was correlated well with poor outcomes (p=.05). This was not the case of arterial or venous lactate measurements. The positive lactate clearance was present in the majority of patients (83.3%) but it did not predict the outcomes (p=.435) and there was no correlation between the baseline lactate and the clinical outcome (p>.05). CONCLUSION In non intensive care settings, capillary lactate level could be a more sensitive method than the classical lactate measurement for predicting the outcomes of acute conditions, especially infectious. A persistently high lactate level rather than its initial value or clearance seems to correlate better with poorer outcomes. ABBREVIATIONS SSC = Surviving sepsis campaign, ED = Emergency department, ICU = intensive care unit, , POC = Point of care, ICC = inter class coefficient.
Collapse
Affiliation(s)
- A Purcarea
- Internal Medicine, “Hopital Civil” Hospital, Strasbourg, France,Internal Medicine Department, Internist.ro, Brasov, Romania
| | - A Bourgarit
- Internal Medicine Department, Internist.ro, Brasov, Romania,Internal Medicine, “Hautepierre” Hospital, Strasbourg, France
| | - A Sovaila
- Internal Medicine Department, Internist.ro, Brasov, Romania,Internal Medicine, “Hautepierre” Hospital, Strasbourg, France
| | - C Ghiura
- Internal Medicine, “Hopital Civil” Hospital, Strasbourg, France
| | - P Diemunsch
- Anesthesiology, Critical Care and Prehospital Emergency Medicine, Strasbourg, France
| | - E Andres
- Internal Medicine, “Hopital Civil” Hospital, Strasbourg, France
| |
Collapse
|
39
|
Fraison J, Mekinian A, Braun T, Grignano E, Ades L, Brechignac S, Gardin C, Bourgarit-Durand A, Andres E, Fenaux P, Fain O. Hypervitaminémie B12 dans les syndromes myélodysplasiques : facteur de mauvais pronostic ? Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
40
|
Laclaustra M, Hurtado-Roca Y, Sendin M, Leon M, Ledesma M, Andres E, Fernandez-Ortiz A, Guallar E, Ordovas JM, Casasnovas JA. Lower-normal TSH is associated with better metabolic risk factors: A cross-sectional study on Spanish men. Nutr Metab Cardiovasc Dis 2015; 25:1095-1103. [PMID: 26552743 DOI: 10.1016/j.numecd.2015.09.007] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/04/2015] [Revised: 09/08/2015] [Accepted: 09/14/2015] [Indexed: 12/13/2022]
Abstract
BACKGROUND AND AIMS Subclinical thyroid conditions, defined by normal thyroxin (T4) but abnormal thyroid-stimulating hormone (TSH) levels, may be associated with cardiovascular and metabolic risk. More recently, TSH levels within the normal range have been suggested to be associated with metabolic syndrome and cardiovascular risk. This work studies the linearity of the relationship between metabolic syndrome and TSH across the euthyroid range. METHODS AND RESULTS We studied 3533 male participants of the Aragon Workers' Health Study (AWHS) with normal TSH and free T4 levels, across quintiles of these variables, after adjusting for age, alcohol intake, and smoking. Compared with the lowest TSH quintile, the odds ratios for metabolic syndrome at the higher quintiles, which indicate lower thyroid function, were 1.34 (1.04, 1.73), 1.56 (1.21, 2.01), 1.57 (1.22, 2.03), and 1.71 (1.32, 2.21). The lowest free T4 quintile also showed an odds ratio of 1.49 (1.16, 1.90) with respect to the highest quintile. In addition, spline models showed departures from linearity: the risk of metabolic syndrome mostly increases at TSH values below the median (sample half-closest to subclinical hyperthyroidism). Interestingly, glucose also increases with TSH primarily below the median TSH, diastolic blood pressure shows similar changes across the entire TSH range, whereas body mass index, triglycerides, and high-density lipoprotein (HDL)-cholesterol change only at the highest normal TSH values, which are associated with lower free T4 concentration. CONCLUSIONS TSH and free T4 within the normal range are associated with the metabolic syndrome. The sample half-below the TSH median (with probably higher functional thyroid status) exhibited better metabolic and cardiovascular profiles.
Collapse
Affiliation(s)
- M Laclaustra
- Clinical Research Department, Spanish National Center for Cardiovascular Research (CNIC), Madrid, Spain; Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain; Department of Epidemiology, St. Louis University, St Louis, MO, USA.
| | - Y Hurtado-Roca
- Clinical Research Department, Spanish National Center for Cardiovascular Research (CNIC), Madrid, Spain
| | - M Sendin
- Clinical Research Department, Spanish National Center for Cardiovascular Research (CNIC), Madrid, Spain
| | - M Leon
- Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain
| | - M Ledesma
- Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain
| | - E Andres
- Instituto de Investigación 12 de Octubre, CIBER-Epidemiología y Salud Pública, Madrid, Spain
| | - A Fernandez-Ortiz
- Clinical Research Department, Spanish National Center for Cardiovascular Research (CNIC), Madrid, Spain
| | - E Guallar
- Department of Epidemiology, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Medicine, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - J M Ordovas
- Clinical Research Department, Spanish National Center for Cardiovascular Research (CNIC), Madrid, Spain
| | - J A Casasnovas
- Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain
| |
Collapse
|
41
|
Zulfiqar AA, Mahdi R, Pennaforte JL, Novella JL, Andres E. P-264: Autoimmune hemolytic anemia in the elderly over 75 years: report of a rare retrospective study. Eur Geriatr Med 2015. [DOI: 10.1016/s1878-7649(15)30362-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
42
|
Salmon JH, Cacoub P, Combe B, Sibilia J, Pallot-Prades B, Fain O, Cantagrel A, Dougados M, Andres E, Meyer O, Carli P, Pertuiset E, Pane I, Maurier F, Ravaud P, Mariette X, Gottenberg JE. Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry. RMD Open 2015; 1:e000034. [PMID: 26509060 PMCID: PMC4612695 DOI: 10.1136/rmdopen-2014-000034] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2014] [Revised: 04/23/2015] [Accepted: 04/28/2015] [Indexed: 01/12/2023] Open
Abstract
Objectives To evaluate the prevalence of late-onset neutropenia and its complications in patients treated with rituximab (RTX) for rheumatoid arthritis (RA) and other autoimmune diseases (AIDs) in a prospective registry. Methods The AutoImmunity and Rituximab registry is an independent 7-year prospective registry promoted by the French Society of Rheumatology. For each episode of neutropenia, data were validated by the clinician in charge of the patient. Results Among 2624 patients treated with RTX for refractory AIDs, and at least 1 follow-up visit (a total follow-up of 4179 patient-years in RA and 987 patient-years in AIDs), late-onset neutropenia was observed in 40 patients (25 RA (1.3% of patients with RA, 0.6/100 patient-years), and AIDs in 15 (2.3% of patients with AIDs, 1.5/100 patient-years)). 6 patients (15%) had neutrophils <500/mm3, 8 (20%) had neutrophils between 500 and 1000/mm3, and 26 (65%) had neutrophils between 1000 and 1500/mm3. Neutropenia occurred after a median period of 4.5 (3–6.5) months after the last RTX infusion in patients with RA, and 5 (3–6.5) months in patients with AIDs. 5 patients (12.5%), 4 of them with neutrophils lower than 500/mm3, developed a non-opportunistic serious infection and required antibiotics and granulocyte colony-stimulating factor injections, with a favourable outcome. After resolution of their RTX-related neutropenia, 19 patients (47.5%) were re-treated, and neutropenia reoccurred in 3 of them. Conclusions Late-onset neutropenia might occur after RTX and may result in serious infections. Thus, monitoring of white cell count should be performed after RTX. However, in this large registry of patients with AIDs, the frequency of RTX-induced neutropenia was much lower than that previously reported in patients treated for blood malignancies or AIDs.
Collapse
Affiliation(s)
- J H Salmon
- Rheumatology Department, CHU Reims, Reims, France
| | - P Cacoub
- Departement Hospitalo-Universitaire I2B, UPMC Univ Paris 06, CNRS, UMR 7211, INSERM, UMR_S 959, Department of Internal Medicine, Groupe Hospitalier Pitié-Salpêtrière (AP-HP), Paris, France
| | - B Combe
- Rheumatology Department, Lapeyronie University Hospital, Montpellier I, University, UMR5535, Montpellier, France
| | - J Sibilia
- Rheumatology department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, INSERM UMRS_1109, Université de Strasbourg, Strasbourg, France
| | - B Pallot-Prades
- Rheumatology Department, CHU Saint-Etienne, Saint-Etienne, France
| | - O Fain
- Department of Internal Medicine, Hôpital Jean Verdier, Bondy, France
| | - A Cantagrel
- Rheumatology Center, Purpan Hospital, Paul Sabatier University, Toulouse, France
| | - M Dougados
- Medicine Faculty, Paris-Descartes University, Paris, UPRES-EA 4058, Cochin Hospital, Rheumatology B, Paris, France
| | - E Andres
- Department of Internal Medicine, University Hospital of Strasbourg, Strasbourg, France
| | - O Meyer
- Rheumatology Department, GroupeHospitalier Bichat-Claude Bernard (AP-HP), Paris, France
| | - P Carli
- Department of Internal Medicine, Hôpital D'Instruction des Armeés Sainte-541 Anne, Toulon, France
| | - E Pertuiset
- Rheumatology Department, CH René Dubos, Pontoise, France
| | - I Pane
- Centre de Recherche en Epidémiologie et Statistiques, INSERM U1153, Centre d'Épidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Descartes University, Paris, France
| | - F Maurier
- Department of Internal Medicine, CHR Metz, Metz, France
| | - P Ravaud
- Centre de Recherche en Epidémiologie et Statistiques, INSERM U1153, Centre d'Épidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Descartes University, Paris, France
| | - X Mariette
- Rheumatology Department, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM U1184, IMVA: Center of Immunology of Viral Infections and Autoimmune Diseases, Paris, France
| | - J E Gottenberg
- Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, CNRS, Institut de Biologie Moléculaire et Cellulaire, Immunopathologie et Chimie Thérapeutique/Laboratory of Excellence Medalis, Université de Strasbourg, Strasbourg, France
| |
Collapse
|
43
|
Andres E, Mecili M, Zulfiqar A, Mourot-Cottet R, Serraj K, Keller O. Comparaison des phénotypes et du devenir des patients sous AOD et AVK au long cours : étude rétrospective de 417 patients. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Andres E, Mecili M, Zulfiqar A, Keller O, Serraj K, Mourot-Cottet R. Phénotype clinique et impact des comorbidités chez des patients sous anticoagulation au long cours et pris en charge en médecine interne : étude rétrospective de 417 patients. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
45
|
Keller O, Mourot-Cottet R, Vogel T, Weber J, Kaltenbach G, Bourgarit A, Andres E. Anémie et insuffisance cardiaque. Étude de 317 patients. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
46
|
Martin-Malo A, Aljama P, Pasalodos J, Sancho M, Valles E, Moreno E, Gomez J, Perez R, Burdiel LG, Andres E. Effects of haemodialysis and haemofiltration on myocardial function. Contrib Nephrol 2015; 41:403-8. [PMID: 6525863 DOI: 10.1159/000429318] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
47
|
Olivas E, Jiménez C, López A, Andres E, Sánchez Tárraga L. Reduction of the incidence of peritonitis in CAPD: effectiveness of heat sterilization of Safe. Lock connectors. Contrib Nephrol 2015; 89:62-7. [PMID: 1893744 DOI: 10.1159/000419751] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- E Olivas
- Nephrology Service, General Hospital, Albacete, Spain
| | | | | | | | | |
Collapse
|
48
|
Andres E, Brandt C, Bersenev E, Suvorov A, Morukov B, Aubert A. Télé-auscultation cardiaque et pulmonaire dans l’expérience Mars 500. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
49
|
Andres E, Talha S, Ahmed Benyahia A, Keller O, Hajjam M, Hajjam A, Moukadem A, Hajjam J, Erve S, Dieterlin A. Projet E-care : déploiement d’un système de détection automatisé des situations à risque de décompensation cardiaque dans une unité de médecine interne. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.062] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
50
|
Zulfiqar A, Andres E, Mahmoudi R, Novella J. P189: Hypervitaminosis B12 in the elderly: about a case-report and review of the literature. Eur Geriatr Med 2014. [DOI: 10.1016/s1878-7649(14)70364-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|